z-logo
open-access-imgOpen Access
Awareness Toward Mucormycosis Attack for COVID Patients
Author(s) -
Meet Kamal Dwivedi,
Ashutosh Dwivedi
Publication year - 2021
Publication title -
microbiology insights
Language(s) - English
Resource type - Journals
ISSN - 1178-6361
DOI - 10.1177/11786361211053003
Subject(s) - mucormycosis , covid-19 , medicine , thrush , immune system , diabetes mellitus , intensive care medicine , dermatology , immunology , disease , surgery , pathology , infectious disease (medical specialty) , cervical cancer , cancer , human papilloma virus , endocrinology
Risk groups for mucormycosis include persons with immunosuppressed immune system and uncontrolled diabetes. The patients suffering from corona virus or post covid patients have been found to be entrapped with this fungal infection due to suppression in the immune system. Also the major attack was reported in those patients who were in Intensive Care units. It arises due to the fungal infection of various species and can occur simultaneously with covid. The development of black fungus mostly affects lungs, eyes, brain, and skin and is not at all contagious. Proper diagnostic can only predict that the patient is in invasive attack of which mucor species. It is better to take prevention by wearing medicated masks, hand gloves, wearing glasses, avoid dusty and damp places.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom